study question: How does a protocol based on a single serum progesterone measurement perform as a triage tool in women with pregnancy of unknown location (PUL) in comparison to protocols based on serial hCG measurement? summary answer: Triage based on the logistic regression model M4 (using initial hCG and hCG ratio (48 h/0 h)) classifies the majority of PUL into low and high risk groups, in contrast to a progesterone protocol based on a serum level threshold of 10 nmol/l. what is known already: Low progesterone has been shown to identify failing pregnancies and those at low risk of complications.
Introduction
A pregnancy of unknown location (PUL) can be defined as the clinical scenario whereby despite a positive urinary pregnancy test, no pregnancy can be visualized using transvaginal ultrasonography (TVS) either inside or outside the endometrial cavity. Between 8 and 31% of women attending for ultrasound scans in early pregnancy are characterized as having a PUL (Hahlin et al., 1995; Banerjee et al., 1999; Van Mello et al., 2012) . To some extent, PUL is an iatrogenic phenomenon, as the likelihood of a PUL increases inversely with gestational age. The use of highly sensitive home pregnancy tests and the tendency for women to present for earlier ultrasound scans increase the chances of a pregnancy being classified as a PUL in its early stages (Bottomley et al., 2009) . Expectant management of PUL has been shown to be safe and reduce the need for unnecessary surgical intervention (Condous et al., 2003) . Until recently research on the management of PUL has focused on predicting the pregnancy location in order to identify ectopic pregnancies (EP).
The management of PUL often involves prolonged follow-up with multiple clinic visits and blood tests before the outcome of the pregnancy is clear. However between 54 and 70% of women with a PUL have a spontaneously resolving pregnancy and majority of the rest have intrauterine pregnancy (IUP) which subsequently become visible with ultrasound (Condous et al., 2006; Kirk et al., 2009) . Introducing ways to reduce the follow-up required for these women whilst identifying women at high risk of complications would be of benefit. Recently, a triage protocol using the prediction model M4 was published Van Calster et al., 2013) . M4 is a multinomial logistic regression model based on the initial serum hCG level and the hCG ratio (48 h/0 h). Entering these values into the M4 formula (see Supplementary data) returns estimated risks of the PUL being a failed PUL, IUP or EP. The protocol classifies women with PUL as low risk if the estimated risk of EP is ,5% and at high risk otherwise. Using this model, PUL classified as at low risk are further classified as failed PUL or IUP. Follow-up is then based on the categorization of PUL, with either a urinary pregnancy test or TVS after 2 weeks for low risk women, and further review for a repeat TVS and/ or serum hCG measurements for women classed as at high risk. M4 was validated in two studies, reporting areas under the receiver operating characteristic curve between 0.84 and 0.89 for the discrimination between EP and non-EP Van Calster et al., 2013) .
A recent meta-analysis and systematic review of the use of single measurements of serum progesterone showed that although it has no value for the prediction of pregnancy location, it is a good discriminator between viable and non-viable pregnancy (Verhaegen et al., 2012) . Measurements of serum progesterone have been used as a tool for predicting pregnancy viability and follow-up requirements for women with a PUL. Day et al. (2009) showed that women with a PUL and initial serum progesterone of ≤10 nmol/l are likely to have a failing pregnancy, and so may require minimal follow-up. Cordina et al. (2011) subsequently used the same protocol prospectively. Of 676 PUL, 252 were classified as failing and only four of these needed intervention. These results although not externally validated are of interest, though with 252 failing PUL in the study, and with 10% of these cases lost to follow-up, it is hard to make a definitive comment on safety. However both these studies are from the same unit and this approach has not undergone external validation, nor has it been compared side by side with triage based on the use of the serum hCG ratio or the prediction model M4.
The primary objective of our study was to compare the performance of serum progesterone-based triage with the M4-based triage protocol using both the initial hCG level and serial hCG measurements. We focus on a progesterone threshold of 10 nmol/l, but also evaluate thresholds of 16 and 20 because such triage protocols have also been reported (Verhaegen et al., 2012) . Finally, we aimed to assess the performance of the previously published hCG ratio cut-offs of 0.87 and 1.66 with a PUL being classified as at high risk if the hCG ratio was between 0.87 and 1.66 (Condous et al., 2004) .
Materials and Methods

Design and setting
This is a multi-centre observational diagnostic accuracy study in women with a PUL. Data were collected at three teaching hospitals: St. George's Hospital (SGH) and Queen Charlottes and Chelsea Hospital (QCCH) in London (UK), and the Royal Prince Alfred Hospital (RPAH) in Sydney (Australia). Data from SGH were collected as part of a strictly defined study protocol Kirk et al., 2007) At SGH and RPAH, women were classified as having a PUL if there was no evidence of an intra or extra-uterine pregnancy on TVS. Data collection at QCCH was according to new definitions of PUL contained within a recent consensus paper (Barnhart et al., 2011) . This includes women with small possible intrauterine gestation sacs or small adnexal masses suggestive of a possible EP where embryonic structures have not been visualized. All women classified as having a PUL on the initial scan were recruited except for women who were clinically unstable or had an acute abdomen at presentation.
All women had a brief history taken, including any previous history of EP, and the amount of vaginal bleeding (expressed as a pictorial bleeding assessment score of 1 -4) (Bottomley et al., 2009) and pain (expressed using a 10 cm visual analogue scale) were noted. All women underwent a TVS performed by an appropriately trained examiner (a nurse specialist, gynaecologist or sonographer).
Data collection
Women who were classified as having a PUL had an initial serum hCG and progesterone measurement and scheduled to have a repeat serum hCG Single progesterone versus serial hCG triage measurement 2 days later. Clinically if the initial hCG ratio was ,0.87 indicating a failing pregnancy, a further serum hCG measurement was taken on Day 7 and if this continued to show a decline in hCG the patient was asked to carry out a urine pregnancy test (UPT) at home 2 weeks later and inform the unit of the result. If the hCG ratio was .1.66, the patients were brought back for a further TVS in 10 -14 days to confirm pregnancy location and viability. If the hCG ratio was between 0.87 and 1.66, the PUL was classified as high risk and brought back immediately for a TVS by a senior sonographer/consultant physician and further hCG measurements if required. All pregnancies were followed up until the final outcome of the pregnancy was known.
The final outcome for the pregnancy was defined as: (i) Failed PULpatients were followed up until the serum hCG was ,15 or a UPT was negative. (ii) EP-visualized using TVS or at laparoscopy or laparotomy. Patients with static hCG levels (,15% change in 2 days) on three consecutive occasions (persistent PUL) were categorized as EP. (iii) IUP-diagnosed using TVS on the basis of the visualization of an intrauterine gestational sac with or without a yolk sac or fetal pole or heterogeneous tissue in the uterine cavity consistent with retained products of conception.
The following interventions for EP were recorded: salpingectomy or salpingostomy via laparoscopy or laparotomy, medical management of EP with methotrexate, and expectant management.
Statistical analysis
For each triage protocol and each centre, we computed the percentage of PUL that were classified as at high risk separately for each outcome (failed PUL, IUP, EP), the percentage of PUL whose classification as at low risk was correct as the final outcome was a failed PUL or IUP, and the overall percentage of PUL classified as at low risk. To account for clustering by centre, overall results were obtained through logistic regression with centre as a fixed effect covariate. By dichotomizing outcome into low risk (failed PUL and IUP) and high risk (EP), diagnostic odds ratios (DOR) were computed for each protocol using the Cochran-Mantel-Haenszel method to stratify by centre. The value represents the ratio of the odds of classification as at high risk for EP versus low risk PUL.
Missing data regarding progesterone, hCG levels or the final diagnosis were handled using multiple imputation (Sterne et al., 2009 ). The chained equations method (White et al., 2011) was used with 100 iterations. The method essentially boils down to an iterative series of regression models for each incomplete variable included in the procedure. Missing values were imputed 100 times, leading to 100 imputed versions of the original dataset. Information on the following variables was used to generate imputations: maternal age, level of vaginal bleeding, logarithm of the initial hCG level, logarithm of the hCG level 48 h later, logarithm of the initial progesterone level and PUL outcome. Vaginal bleeding and PUL outcome were represented as nominal variables in the imputation process, which was performed separately for each centre. Convergence was assessed graphically (van Buuren and Groothuis-Oudshoorn, 2011), and was satisfactory. The standard Rubin's rules were used to combine results from each imputed dataset in order to obtain a final result. Results based on complete cases only were also obtained as a sensitivity analysis. Results based on multiple imputation showed slightly more modest performance of the triage protocols and were reported in the manuscript (unless stated otherwise).
The imputation of missing values was carried out with IVEware v0.2 (http ://www.isr.umich.edu/src/smp/ive/), and all other statistical analyses with SAS 9.3 (SAS Institute, Cary, NC, USA).
Results
There were 1271 women diagnosed with PUL in total, 534 from SGH, 585 from QCCH and 152 from RPAH. Fifty-eight women (4.6%) were lost to follow-up, 36 at SGH, 21 at QCCH and 1 at RPAH. Another 290 women (22.8%) did not have complete hCG and progesterone information: 67 at SGH, 168 at QCCH and 55 at RPAH. This leaves 923 complete cases (72.6%), with missing values for the 348 incomplete cases handled using multiple imputation. A study flowchart is shown in Fig. 1 . Incomplete hCG and progesterone information arose for the following reasons: (i) the patient had an initial hCG level of ,30 and was followed up with a UPT only; (ii) a diagnosis of an IUP or EP was made using TVS prior to the second hCG level; (iii) the patient underwent an intervention prior to the second hCG; (iv) progesterone not measured at admission as admitted via the emergency department. Table I shows the descriptive results by centre and outcome. Failed PUL rates were 53% (SGH), 64% (QCCH) and 74% (RPAH); IUP rates were 39% (SGH), 23% (QCCH) and 17% (RPAH); EP rates were 8% (SGH), 13% (QCCH), 9% (RPAH).
A single-visit progesterone protocol using a progesterone cut-off of ≤10 nmol/l classified 24% (95% CI 20-28%) of failed PUL, 95% (92 -97%) of IUP and 76% (67 -83%) of EP as at high risk (Table II) . For all PUL, 52% (49 -56%) of pregnancies were classified as at low risk and would qualify for limited follow-up. Of pregnancies classified as at low risk, 95% (93-97%) were indeed failed PUL or IUP. This suggests that, amongst PUL classified as at low risk using progesterone, about 1 in 21 would be an EP. Progesterone protocols that use a higher cut-off classify 40 -60% of EP as at high risk yet still classify at least 89% of IUP as at high risk. Therefore, we will focus on results for the 10 nmol/l cut-off in what follows.
The M4-based protocol classified 14% (11 -17%) of failed PUL, 37% (31 -43%) of IUP and 84% (76 -90%) of EP as at high risk. For all PUL this protocol classified 73% (70 -76%) of PUL as at low risk, and amongst these 98% (96-99%) were indeed failed PUL or IUP. Thus, of PUL classified as at low risk using M4, about 1 in 48 would be an EP.
Finally, the protocol using hCG ratio cut-offs classified 10% (8-12%) of failed PUL, 15% (11 -20%) of IUP and 63% (53 -71%) of EP as at high risk. For all PUL this protocol classified 84% (81 -86%) of PUL as at low risk, and among these 96% (94-97%) were indeed failed PUL or IUP. Hence for PUL classified as low risk using the hCG ratio, about 1 in 23 would be an EP.
Further investigation reveals that EP classified as at low risk by progesterone were mostly different pregnancies to those classified as at low risk using the M4 protocol (Fig. 2 , based on complete cases only).
DORs were 3.61 (2.30-5.66) for the progesterone protocol (based on a cut-off of .10 nmol/l), 19.4 (11.5-32.8) for the M4 protocol, and 13.1 (8.57-20.2) for the hCG ratio cut-offs. For each protocol, the results were comparable across centres.
Of all 98 EP that were complete cases, 12 were managed expectantly, 48 were treated with methotrexate, 37 underwent surgical intervention and one was lost to follow-up (Table III) . The progesterone protocol classified 8/12 (67%) EP managed expectantly, 32/48 (67%) EP that received methotrexate and 33/37 (89%) EP treated surgically as at high risk. In comparison, the M4-based protocol classified 9/12 (75%), 46/48 (96%) and 30/37 (81%) as at high risk, respectively. These results mainly suggest a difference for EP treated with methotrexate. Finally, the hCG ratio cut-offs correctly classified 7/12 (58%), 36/48 (75%) and 24/37 (65%) as at high risk, respectively.
Discussion
Our study shows that both the M4 model and the hCG ratio are better triage tools for classifying women with a PUL into low and high risk groups than a single measurement of serum progesterone at presentation. Overall the M4 model performs better than both other protocols as it misclassifies significantly fewer EP, whilst correctly allocating the majority of IUP and failed PUL to the low risk group. We have further demonstrated that irrespective of the cut-off value for serum progesterone of 10, 16 or 20 nmol/l, 76 -99% of IUP will be placed into a high risk group in the included centres.
It is of interest to note that in the study by Cordina et al. (2011) , 37% of the PUL had a serum progesterone of ≤10 nmol/l and so were classified as low risk PUL, in comparison to 52% in our study. This is likely to represent different proportions of pregnancy outcome in different centres. A plausible explanation would be that more women with possible retained products in the uterine cavity were classified as PUL in our study than is the case in the Cordina study (Cordina et al., 2011) .
In the study by Cordina et al. (2011) , a modification of the serum progesterone protocol was used to manage patients based on defining a high risk PUL based on either serum progesterone levels between 20 and 60 nmol/l with a serum hCG of .25 IU/l, or a progesterone of .60 nmol/l and a serum hCG of .1000 IU/l. This amended protocol still classified over 50% of IUP as high risk PUL and allocated around 60% of EP into the low risk category (see Supplementary data, Table SI ). This specific combination of hCG and progesterone information does not seem a viable triage strategy.
The principal problem with triage based on single measurements of serum progesterone is the classification of the majority of IUP as being at high risk, as is illustrated in Table II . The result is that progesterone triage incorrectly classifies over twice as many low risk PUL as at high risk compared with triage based on either the hCG ratio or M4. This limitation is reflected in the far higher DOR's seen for hCG based triage compared with serum progesterone. The argument in favour of using serum progesterone triage is that it is based on a single blood test and/or clinic visit, whereas hCG triage requires two blood tests 48 h apart. In this way a proportion of women may have their follow-up arrangements rationalized at an earlier stage. Our study suggests that such an approach would be associated with a significant number of EP being classified as being at low risk, for whom reduced follow-up may represent a significant clinical risk. This finding is consistent with a previous study that reported a significant false negative rate for EP when a single-visit strategy using serum progesterone is used (Condous et al., 2004) .
An important consideration is whether classifying some women with EP as being at low risk is of clinical importance. If EP classified at low risk with progesterone are mostly failing pregnancies, then we might expect the majority to resolve in any event without the need for intervention and with minimal complications (Mavrelos et al., 2013) . Our study is not designed to answer this question, however if we examine the management selected for EP in the study we can see that a progesterone protocol based on levels of .10 nmol/l classified 33% of EP that received methotrexate treatment as being low risk compared with just 4% for the M4 model. This suggests that some cases with rising hCG levels are classed at low risk with progesterone. This may or may not be a clinical problem, as we do not know if the EP with low progesterone in our study would eventually "turn the corner" leading to a decline in hCG levels. Single progesterone versus serial hCG triage Whatever approach is made to PUL triage, no test will ever be perfect and some women with EP will inevitably be classified as being at low risk. Accordingly whether to use any kind of triage strategy for PUL depends on the likely compliance of the patient population and the health care environment. We know that most EP in the PUL population are not detected because they are too small and early in their natural history (Kirk et al., 2008) . It is therefore unlikely that an EP in a PUL population will be subject to catastrophic rupture in a matter of days without any warning in terms of pain. If patients cannot be relied upon to report changes in their symptoms, then a more aggressive diagnostic approach may be needed to obtain a definitive answer at an earlier stage. Irrespective, when dealing with diagnostic tests such as measurements of serum hCG and progesterone or ultrasound, it is fundamental to always treat the patient and not the test result.
A strength of this study is that it contains relatively large numbers and the multi-centre data collection means the results are more likely to be generally applicable. A weakness is that a proportion of subjects had missing information on serum measurements of progesterone and hCG; however, we are reassured by the minimal differences seen between the results of complete cases and those following imputation of missing values. The variation in the inclusion criteria between the three centres is also a potential limitation of this study; however, it reflects real clinical practice. In many centres, less experienced sonographers despite visualizing a small intrauterine gestational sac or an adnexal mass may classify women as PUL.
Single values of serum hCG have also been shown to have limited value as a triage tool. Condous et al. (2005) showed that the sensitivity and specificity of an hCG level of .1000 IU/l to detect EP were 21.7% (10/46) and 87.3% (420/481), respectively; for an hCG level of .1500 IU/l these values were 15.2% (7/46) and 93.4% (449/481), respectively, and for an hCG level of .2000 IU/l they were 10.9% (5/46) and 95.2% (458/481), respectively. A further strategy to explore would be to use progesterone for initial triage, followed by a further rationalization of follow-up using M4 or the hCG ratio at 48 h. In this context it is important to note that EPs misclassified by progesterone-based triage using 10 nmol/l were all but one correctly classified by the M4 model and vice versa. This means that EP misclassified with progesterone would be lost to follow-up, and a further group of EP would be misclassified at 48 h with hCG triage. There is likely to be an optimal combined approach using progesterone-based triage. Such an approach may involve use of the initial hCG combined with low progesterone at the time of an initial scan, followed by further hCG triage at 48 h. This should avoid intensive follow-up for the majority of women with a PUL attending clinic. Single progesterone versus serial hCG triage
The management of PUL has changed from being orientated towards identifying pregnancy location, to an evaluation of viability and subsequent triage. This reflects a general clinical view that many women with PUL undergo too many tests and hospital visits. This change in approach is reflected in recent guidance published by NICE (NICE Guideline, 2012) with low risk PUL being advised to carry out a urinary pregnancy test at home after an interval. However it is clearly important that triage is as accurate as possible. Our study supports the view given by NICE that triage be based on serum hCG rather than measurements of serum progesterone. Our data also suggest that when carrying out triage based on serum hCG the initial serum hCG should be taken into account as well as the ratio. 
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